Navigation Links
H. D. Smith Completes Acquisition Of Pharmaceutical Support Services Company Triplefin
Date:6/20/2013

hysician offices, specialty and retail pharmacies; and a trusted supplier for patients expecting reliable access to prescription medicines."

With the transaction now complete, Smith Medical Partners' customers will benefit from expanded service offerings provided by Triplefin, including critical distribution/fulfillment, marketing, pharmacy services, technology and specialty product education functions.  The combined organization will support offerings to specialty product manufacturers and pharmacy partners previously provided by Smith Medical Partners.

"The specialty health services model of today does more than just ensure that a product travels safely and securely from manufacturer to patient.  Today's model must ensure that the needs of pharmacists, physicians, payers, group purchasing organizations, and patients are met – from patient-care information and education materials to clinical needs.  Meeting these multiple mandates requires highly specialized fulfillment complimented with specialized handling and patient treatment support services that provide the safety, security and knowledge to successfully treat the patient," said Joseph Conda, president of H. D. Smith Specialty Solutions.  "With a larger and more diversified Specialty Solutions portfolio, we are now well equipped to provide varied services and support functions for all of the players involved in the care and treatment of patients requiring specialty pharmaceuticals."

About H. D. Smith
Headquartered in Springfield, Illinois, H. D. Smith is among the largest national full-line, full-service wholesalers providing a complete line of prescription products, OTCs, HBAs, home healthcare products, durable medical equipment, seasonal merchandise and a wide array of marketing programs to retail pharmacies, regional chains and health systems. The company h
'/>"/>

SOURCE H. D. Smith
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Upsher-Smith Is Honored With Prestigious Industry Award For Leadership And Innovation
2. Upsher-Smith Successfully Completes Phase III Study Of USL255 (Extended-Release Topiramate) For Adjunctive Treatment Of Epilepsy In Patients With Refractory Partial-Onset Seizures
3. Upsher-Smith Introduces Newly Redesigned Corporate Website
4. Merck and Celebrity Chef Art Smith "Cook Up a Recipe" for Better Type 2 Diabetes Management
5. CIOs von GlaxoSmithKline und British American Tobacco als Referenten auf führender Strategie-Veranstaltung für Unternehmensmobilität
6. CIOs of GlaxoSmithKline and British American Tobacco to Speak at Leading Enterprise Mobility Strategy Event
7. GlaxoSmithKline CFO Interviewed on Q1 2013 Financial Results
8. GlaxoSmithKline and A*STARs Institute of Chemical Engineering and Sciences to Develop new Medicines for Emerging Markets
9. GlaxoSmithKline and Liberty Property Trust/Synterra Partners Transform the Work Environment with the Opening of Five Crescent Drive Today
10. GlaxoSmithKline and Liberty Property Trust/Synterra Partners Transform the Work Environment with the Opening of Five Crescent Drive
11. Texas A&M System and GlaxoSmithKline receive U.S. Government approval to establish influenza vaccine facility in Texas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... -- Pharmaceutic Labs announces the opening of its specialty ... for admixing, compounding, drug shortages and clinical ... FDA standards for safety and quality, using 21 CFR ... The 10,000 square foot outsourcing facility was designed ... quality control. The company will produce sterile and non-sterile ...
(Date:10/20/2014)... and RALEIGH, N.C., Oct. 20, 2014  BioPontis Alliance ... (HNF), both philanthropies, announced today the creation of ... the treatment of the rare disease known as ... announced its alliance model earlier this month. Today,s ... of a collaborative model where researchers and all ...
(Date:10/19/2014)... , Oct. 19, 2014  Henry Schein, Inc. (NASDAQ: ... health care products and services to office-based dental, animal ... invested in Iwase Dental Supply, Inc., a leading full-service ... transaction marks Henry Schein,s entrance into Japan ... market, and increases to 28 the number of countries ...
Breaking Medicine Technology:The Hereditary Neuropathy Foundation and BioPontis Alliance for Rare Disease Partner to Develop Treatments for Charcot-Marie-Tooth 2The Hereditary Neuropathy Foundation and BioPontis Alliance for Rare Disease Partner to Develop Treatments for Charcot-Marie-Tooth 3Henry Schein Enters Japan With Investment in Iwase Dental Supply 2Henry Schein Enters Japan With Investment in Iwase Dental Supply 3Henry Schein Enters Japan With Investment in Iwase Dental Supply 4Henry Schein Enters Japan With Investment in Iwase Dental Supply 5
... June 28, 2011 The Mirixa Corporation and ... are pleased to announce that MirixaPro(SM), a Web-based ... patient care service delivery, will be deployed in ... agreement enabling CACDS to use a scalable, localized ...
... 2011 ,   The ... range of,new clinical data. The "Late-Breaking Clinical Trials" were ... SHPT study,(Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet,With ... June the,principal investigator of this study, Prof. Markus Ketteler,(Coburg, ...
Cached Medicine Technology:Mirixa and CACDS Sign Agreement for Clinical Service Delivery Platform 2Mirixa and CACDS Sign Agreement for Clinical Service Delivery Platform 3Update on IMPACT Study Results 2
(Date:10/20/2014)... NY (PRWEB) October 20, 2014 ... non-profit organization that helps New Yorkers living with ... changes toward health, housing, recovery and self-sufficiency. Each ... transformed the local community through their tireless efforts. ... Marc Shapses , has been selected as ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Zereana Jess-Huff, a ... Mrs. Maryland 2014 on a platform to think outside the ... and uses her position to raise awareness about women’s other ... for breast cancer. You say the color pink and everybody ... know for a fact that it has not been won ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 AttorneyOne.com, a recognized ... latest information from the FDA on Sit and Slim ... 10 not to purchase or use Sit and Slim II ... Slim II is promoted as weight loss product on various ... from the market in 2010 for safety reasons, can significantly ...
(Date:10/20/2014)... CO (PRWEB) October 20, 2014 ... assays are the only imaging assays capable of ... a single test.  With these three dimensions of ... ability to detect the widest range of disease-causing ... usually missed by other genomic tools, including today’s ...
(Date:10/20/2014)... October 20, 2014 It’s hard to imagine ... orphans and vulnerable children around the world, it’s a reality. ... people, many children are forced to walk barefoot on rocky ... families or play with their friends. , Buckner International's ... Air1 Radio in October to encourage support for ...
Breaking Medicine News(10 mins):Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 2Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 3Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3Health News:FDA Advises Not to Use Sit and Slim II: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:KromaTiD Launches Genome Screening and Discovery Services 2Health News:KromaTiD Launches Genome Screening and Discovery Services 3Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 2Health News:Buckner Shoes for Orphan Souls® Garners Support from Air1 Radio 3
... magnetic resonance imaging (MRI) may help physicians differentiate between ... wrist enabling more targeted therapies unique to each condition, ... the American Journal of Roentgenology . Contrast-enhanced MRI ... bodily structures. Rheumatoid arthritis ...
... ... ... ... ...
... ... ... , ... SPOKANE, Wash. , Feb. 18 On January 29, 2010 , Sacred Heart Medical Center was cited and ...
... cooling devices, , THURSDAY, Feb. 18 (HealthDay News) -- ... keep vaccines stable without the use of refrigerators or ... , The vaccine storage technology, developed by scientists ... could help eliminate the need for refrigeration, which is ...
... Feb. 18 WebMD Health Corp. (Nasdaq: WBMD ), ... three months and year ended December 31, 2009 . , For ... was $138.1 million , compared to $110.1 million in ... interest, taxes, non-cash and other items ("Adjusted EBITDA") was $46.4 million ...
... After testing dozens of samples from marine mammals, University ... be the ideal model for the study of cervical ... multiple infections of apillomaviruses, which are known to be ... a marine mammal biologist and clinical assistant professor at ...
Cached Medicine News:Health News:Contrast-enhanced MRI could play a key role in differentiating between common types of arthritis 2Health News:NOVAVAX, Inc. Receives NASDAQ Non-Compliance Letter 2Health News:NOVAVAX, Inc. Receives NASDAQ Non-Compliance Letter 3Health News:NOVAVAX, Inc. Receives NASDAQ Non-Compliance Letter 4Health News:Sacred Heart Medical Center Cited for Violation of Safety Standards in H1N1 Prevention 2Health News:Sacred Heart Medical Center Cited for Violation of Safety Standards in H1N1 Prevention 3Health News:New Technology Could Widen Reach of Vaccines 2Health News:WebMD Announces Fourth Quarter Financial Results 2Health News:WebMD Announces Fourth Quarter Financial Results 3Health News:WebMD Announces Fourth Quarter Financial Results 4Health News:WebMD Announces Fourth Quarter Financial Results 5Health News:WebMD Announces Fourth Quarter Financial Results 6Health News:WebMD Announces Fourth Quarter Financial Results 7Health News:WebMD Announces Fourth Quarter Financial Results 8Health News:WebMD Announces Fourth Quarter Financial Results 9Health News:WebMD Announces Fourth Quarter Financial Results 10Health News:WebMD Announces Fourth Quarter Financial Results 11Health News:WebMD Announces Fourth Quarter Financial Results 12Health News:WebMD Announces Fourth Quarter Financial Results 13Health News:WebMD Announces Fourth Quarter Financial Results 14Health News:WebMD Announces Fourth Quarter Financial Results 15Health News:WebMD Announces Fourth Quarter Financial Results 16Health News:WebMD Announces Fourth Quarter Financial Results 17Health News:WebMD Announces Fourth Quarter Financial Results 18Health News:WebMD Announces Fourth Quarter Financial Results 19Health News:WebMD Announces Fourth Quarter Financial Results 20Health News:WebMD Announces Fourth Quarter Financial Results 21Health News:WebMD Announces Fourth Quarter Financial Results 22Health News:WebMD Announces Fourth Quarter Financial Results 23Health News:WebMD Announces Fourth Quarter Financial Results 24Health News:WebMD Announces Fourth Quarter Financial Results 25Health News:WebMD Announces Fourth Quarter Financial Results 26Health News:WebMD Announces Fourth Quarter Financial Results 27Health News:WebMD Announces Fourth Quarter Financial Results 28Health News:WebMD Announces Fourth Quarter Financial Results 29
... Diagnostics offers Q Fever IFA Test Kits ... and IgM human antibody responses to Coxiella ... the simultaneous semi-quantitative detection and differentiation of ... Phase II antigens. By providing the two ...
Claes Shielded Retinotomy Scissors, Vertical...
... is intended for qualitatively detecting antibodies to ... The test is indicated for testing persons ... aid in the presumptive laboratory diagnosis of ... for self-testing, and this test is not ...
... test for the detection and semi-quantitation of ... Encephalitis virus (SLE), Western Equine Encephalitis virus ... California Encephalitis/La Crosse virus (CE). Each kit ... spots of SLE, WEE, EEE, and CE ...
Medicine Products: